Research Article - (2012) Volume 4, Issue 1
Durability of First Line Antiretroviral Therapy: Reasons and Predictive Factors for Modifications in a Swaziland Cohort
- Simbarashe Takuva1,2,5*, Goedele Louwagie1, Khangelani Zuma2,3 and Velephi Okello4
- 1University of Pretoria, Faculty of Health Sciences, School of Health Systems and Public Health, Pretoria, South Africa, E-mail: stakuva@witshealth.co.za
- 2Mbabane Government Hospital Antiretroviral Therapy Unit, Ministry of Health and Social Welfare, Mbabane, Swaziland, E-mail: stakuva@witshealth.co.za
- 3HIV/AIDS, STIs and TB (HAST), Human Sciences Research Council, Pretoria, South Africa, E-mail: stakuva@witshealth.co.za
- 4Swaziland National AIDS Program, Ministry of Health and Social Welfare, Mbabane, Swaziland, E-mail: stakuva@witshealth.co.za
- 5Clinical HIV Research Unit, Wits Health Consortium, Johannesburg, South Africa, E-mail: stakuva@witshealth.co.za
*Corresponding Author:
Dr. Simbarashe Takuva, Epidemiology and Biostatistics Division, Clinical HIV Research Unit, Wits Health Consortium, Private Bag X 2600, Houghton, Johannesburg 2041, South Africa, Tel: +27112768800, Fax: +27114822130
Email: